Concepedia

Author

Klingemann Hg

Vancouver General Hospital

Also Known As

H G Klingemann, H-G Klingemann, HG Klingemann, Klingemann Hg

53

Publications

7.1K

Citations

21

H-Index

23

Concepts

All Affiliations

Vancouver General HospitalTerry Fox Research InstituteBC Cancer AgencyVancouver Hospital and Health Sciences CentreUniversity of British Columbia
KH

About

Klingemann Hg is an author at Vancouver General Hospital specializing in medicine, cellular therapies, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

199

2

Cellular Therapies

3

3

109

3

Health Sciences

2

2

132

4

Cell Biology

1

1

22

5

Epidemiology

1

1

14

Klingemann Hg

×

29

Publications

6.8K

Citations

20

H-Index

YearCitations

1994 Consensus Conference on Acute GVHD Grading.

Donna Przepiorka, Daniel Weisdorf, Peyton Martin,

PubMed

1995

5.1K

Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy [see comments]

DE Reece, JM Connors, JJ Spinelli,

Blood

1994

217

Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study [see comments]

MJ Barnett, CJ Eaves, GL Phillips,

Blood

1994

150

Successful autografting in chronic myeloid leukaemia after maintenance of marrow in culture.

MJ Barnett, Eaves Cj, Phillips Gl,

PubMed

1989

148

Bone marrow transplantation in patients aged 45 years and older

Klingemann Hg, Rainer Storb, A Fefer,

Blood

1986

147

High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy

DE Reece, MJ Barnett, JD Shepherd,

Blood

1995

122

Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study [see comments]

MJ Barnett, CJ Eaves, GL Phillips,

Blood

1994

121

High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults

GL Phillips, DE Reece, JD Shepherd,

Blood

1991

94

High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults

GL Phillips, DE Reece, JD Shepherd,

Blood

1991

83

Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected] [published erratum appears in Blood 1992 Jun 15;79(12):3397]

Klingemann Hg, AP Grigg, K Wilkie-Boyd,

Blood

1991

80

Page 1